ALLMedicine™ Diabetic Foot Infections Center

Sep 17th, 2020 - Individuals with diabetes and end-stage renal disease (ESRD) are at increased risk of foot ulceration and lower extremity amputation. Although risk factors and microbiologic analysis of diabetic foot infections (DFIs) have been extensively studied...

Sep 11th, 2020 - To develop and evaluate the impact of a new model in which the infectious disease (ID) physician and pharmacist work together to treat diabetic foot infections (DFIs). We conducted a quasi-experimental before-after study. We retrospectively review...

Sep 4th, 2020 - Patients with diabetes, including those with foot complications, are at highest risk for severe outcomes during the COVID-19 pandemic. Diabetic foot ulcers (DFU) present additional challenges given their superimposed risk for severe infections and...

Aug 20th, 2020 - In recent years, the emergence of antibiotic resistant pathogens made increasingly difficult to establish appropriate empiric antimicrobial therapy protocols for acute diabetic foot infection (DFI) treatment. Early recognition of the population at...

Aug 18th, 2020 - Diabetic foot infection (DFI) is an important risk factor for amputation, and late diagnosis or referral is often incriminated for poor outcome. To enable an earlier diagnosis of DFI, comparative foot thermometry has been suggested as a self-scree...

Dec 31st, 2016 - Diabetic foot is one of the most common, costly and severe complications of diabetes. Amputation in people with diabetes is 10 to 20 times more common than in people without diabetes and it is estimated that every 30 seconds a lower limb or part o.

Jan 31st, 2016 - Ulceration of the foot in diabetes is a common complication, can be disabling, and frequently leads to amputation of the leg. The lifetime risk for foot ulcers in people with diabetes has been estimated to be 15% to 25%.

May 23rd, 2012 - Foot infections are a common and serious problem in persons with diabetes. Diabetic foot infections (DFIs) typically begin in a wound, most often a neuropathic ulceration. While all wounds are colonized with microorganisms, the presence of infecti...

Jan 31st, 2012 - Specific guidelines for the treatment of diabetic foot infections 2011.|2012|Lipsky BA,Peters EJ,Berendt AR,Senneville E,Bakker K,|microbiology,prevention & control,microbiology,prevention & control,

Sep 17th, 2020 - Individuals with diabetes and end-stage renal disease (ESRD) are at increased risk of foot ulceration and lower extremity amputation. Although risk factors and microbiologic analysis of diabetic foot infections (DFIs) have been extensively studied...

Sep 11th, 2020 - To develop and evaluate the impact of a new model in which the infectious disease (ID) physician and pharmacist work together to treat diabetic foot infections (DFIs). We conducted a quasi-experimental before-after study. We retrospectively review...

Sep 4th, 2020 - Patients with diabetes, including those with foot complications, are at highest risk for severe outcomes during the COVID-19 pandemic. Diabetic foot ulcers (DFU) present additional challenges given their superimposed risk for severe infections and...

Sep 3rd, 2020 - ZYVOX is an oxazolidinone-class antibacterial indicated in adults and children for the treatment of the following infections caused by susceptible Gram-positive bacteria: Nosocomial pneumonia (1.1); Community-acquired pneumonia (1.2); Complicated ...

Aug 20th, 2020 - In recent years, the emergence of antibiotic resistant pathogens made increasingly difficult to establish appropriate empiric antimicrobial therapy protocols for acute diabetic foot infection (DFI) treatment. Early recognition of the population at...

Sep 13th, 2016 - Many patients with diabetic foot infections receive methicillin-resistant Staphylococcus aureus antibiotics unnecessarily, according to Kelly Reveles, PharmD, and her associates. Among the 318 patients with diabetic foot infections (DFIs) in the s.

Aug 11th, 2014 - Scientific principles Diabetic foot infections are associated with substantial morbidity and mortality. Important risk factors for development of diabetic foot infections include neuropathy, peripheral vascular disease, and poor glycemic control.

Apr 22nd, 2013 - Some slow or nonresponding wounds may benefit from selected adjunctive measures such as bioengineered skin equivalents, growth factors, hyperbaric oxygen therapy, or negative-pressure wound therapy. Multidisciplinary diabetic foot care teams impro.

Jan 4th, 2012 - WASHINGTON -- The FDA has issued an order banning some off-label uses of cephalosporins in cattle, swine, and poultry in order to preserve the effectiveness of the antibiotic class in humans. The order, issued Wednesday by the FDA's Center for Vet...

Nov 10th, 2005 - Action Points Advise patients with moderate-to-severe diabetic foot infections that Invanz may offer an effective and convenient treatment option. Be aware that Monday marks the start of a year-long campaign aimed at reducing the global burden of ...